CIENCIASMEDICASNEWS: Universal Influenza Candidate Vaccine Performs Well in Phase 1 Trial | NIH: National Institute of Allergy and Infectious Diseases

viernes, 21 de abril de 2023

Universal Influenza Candidate Vaccine Performs Well in Phase 1 Trial | NIH: National Institute of Allergy and Infectious Diseases

Universal Influenza Candidate Vaccine Performs Well in Phase 1 Trial | NIH: National Institute of Allergy and Infectious Diseases

No hay comentarios:

Publicar un comentario

Suscribirse a: Enviar comentarios (Atom)